BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 31558845)

  • 1. B-cell receptor immunoglobulin stereotypy in chronic lymphocytic leukemia: Key to understanding disease biology and stratifying patients.
    Agathangelidis A; Chatzikonstantinou T; Stamatopoulos K
    Semin Hematol; 2024 Apr; 61(2):91-99. PubMed ID: 38242773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia.
    Baliakas P; Moysiadis T; Hadzidimitriou A; Xochelli A; Jeromin S; Agathangelidis A; Mattsson M; Sutton LA; Minga E; Scarfò L; Rossi D; Davis Z; Villamor N; Parker H; Kotaskova J; Stalika E; Plevova K; Mansouri L; Cortese D; Navarro A; Delgado J; Larrayoz M; Young E; Anagnostopoulos A; Smedby KE; Juliusson G; Sheehy O; Catherwood M; Strefford JC; Stavroyianni N; Belessi C; Pospisilova S; Oscier D; Gaidano G; Campo E; Haferlach C; Ghia P; Rosenquist R; Stamatopoulos K;
    Haematologica; 2019 Feb; 104(2):360-369. PubMed ID: 30262567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the pathways to chronic lymphocytic leukemia.
    Stevenson FK; Forconi F; Kipps TJ
    Blood; 2021 Sep; 138(10):827-835. PubMed ID: 34075408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia (CLL) in the Era of Next Generation Sequencing.
    Gupta SK; Viswanatha DS; Patel KP
    Front Cell Dev Biol; 2020; 8():357. PubMed ID: 32509784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited susceptibility to CLL.
    Speedy HE; Sava G; Houlston RS
    Adv Exp Med Biol; 2013; 792():293-308. PubMed ID: 24014302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatin activation profiling of stereotyped chronic lymphocytic leukemias reveals a subset 8-specific signature.
    Tsagiopoulou M; Chapaprieta V; Russiñol N; García-Torre B; Pechlivanis N; Nadeu F; Papakonstantinou N; Stavroyianni N; Chatzidimitriou A; Psomopoulos F; Campo E; Stamatopoulos K; Martín-Subero JI
    Blood; 2023 Jun; 141(24):2955-2960. PubMed ID: 36989492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors.
    Moysiadis T; Baliakas P; Rossi D; Catherwood M; Strefford JC; Delgado J; Anagnostopoulos A; Belessi C; Stavroyianni N; Pospisilova S; Oscier D; Gaidano G; Campo E; Rosenquist R; Ghia P; Stamatopoulos K
    Leukemia; 2019 Jul; 33(7):1801-1805. PubMed ID: 30679797
    [No Abstract]   [Full Text] [Related]  

  • 8. The Danish National Chronic Lymphocytic Leukemia Registry.
    da Cunha-Bang C; Geisler CH; Enggaard L; Poulsen CB; de Nully Brown P; Frederiksen H; Bergmann OJ; Pulczynski EJ; Pedersen RS; Nielsen LH; Christiansen I; Niemann CU
    Clin Epidemiol; 2016; 8():561-565. PubMed ID: 27822100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prehistory of chronic lymphocytic leukemia: clues from the B-cell receptor.
    Davi F
    Haematologica; 2024 Mar; 109(3):709-711. PubMed ID: 37731392
    [No Abstract]   [Full Text] [Related]  

  • 10. IGHV gene rearrangements as outcome predictors for CLL patients: experience of Ukrainian group.
    Kryachok I; Abramenko I; Bilous N; Chumak A; Martina Z; Filonenko I
    Med Oncol; 2012 Jun; 29(2):1093-101. PubMed ID: 21503826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological characteristics and clinical significance of stereotyped B-cell receptor in chronic lymphocytic leukemia].
    Qiu TL; Li JY; Xia Y
    Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):197-202. PubMed ID: 38604800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotyped B-cell receptors in chronic lymphocytic leukemia.
    Agathangelidis A; Vardi A; Baliakas P; Stamatopoulos K
    Leuk Lymphoma; 2014 Oct; 55(10):2252-61. PubMed ID: 24397617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia - Czech national study.
    Stranska K; Plevova K; Skuhrova Francova H; Skabrahova H; von Jagwitz-Biegnitz M; Radova L; Panovska A; Hrobkova S; Brychtova Y; Urbanova R; Smolej L; Simkovic M; Zuchnicka J; Mohammadova L; Spacek M; Mayer J; Pospisilova S; Doubek M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):425-434. PubMed ID: 31558845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The
    Perez-Chacon G; Zapata JM
    Front Immunol; 2021; 12():627602. PubMed ID: 33912159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
    Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.